Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery - A randomized controlled pilot study

Annals of Surgical Oncology

Volumn 14, Issue 10, 2007, Pages 2798-2806

  Giger, Urs ^a   Büchler, Markus ^b,c   Farhadi, Jian ^b   Berger, Dieter ^d   Hüsler, Jürg ^b   Schneider, Heinz ^e   Krähenbühl, Stephan ^f   Krähenbühl, Lukas ^a,b  

^a Hopital Cantonal de Fribourg   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Stadtklinik ^*  (Germany)

^e HealthEcon Ltd   (Switzerland)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

C reactive protein (CRP); Cytokines; Endotoxin; Immunonutrition; Perioperative inflammatory response; Postoperative complication

Indexed keywords

C REACTIVE PROTEIN; GLYCINE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL SURGERY; ADULT; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DIGESTIVE SYSTEM CANCER; ELECTIVE SURGERY; FEMALE; HOSPITALIZATION; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; MALE; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UPPER GASTROINTESTINAL TRACT;

ADENOCARCINOMA; ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; ENTERAL NUTRITION; FEMALE; FOOD, FORMULATED; FOOD, FORTIFIED; GLYCINE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PANCREATIC NEOPLASMS; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 34648832090     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9407-7     Document Type: Article

References (32)

1. Braga M, Gianotti L, Radaelli G, Vignali A, Mari G, Gentilini O, Di Carlo V. Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg 1999; 134:428-433
2. Senkal M, Zumtobel V, Bauer KH, Marpe B, Wolfram G, Frei A, Eickhoff V, Kemen M. Outcome and cost effectiveness of perioperative enteral immunonutrition in patients with elective upper gastrointestinal surgery: A prospective randomised study. Arch Surg 1999; 134:1309-16
3. Gianotti L, Braga M, Frei A, Greiner R, Di Carlo V. Health care resources consumed to treat postoperative infections: cost saving by perioperative immunonutrition. Shock 2000; 14:325-330
4. Tepaske R, Velthuis H, Oudemans-van Straaten HM, Heisterkamp SH, van Deventer SJ, Ince C, Eysman L, Kesecioglu J. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomized placebo-controlled trial. Lancet 2001; 358:696-701
5. Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 2002; 122:1763-70
6. Pscheidl E, Schywalsky M, Tschaikowsky K, Böke-Pröls T. Fish oil-supplemented parenteral diets normalize splanchnic blood flow and improve killing of translocated bacteria in a low-dose endotoxin rat model. Crit Care Med 2000; 28:1489-96
7. Weimann A, Jauch K.W, Kemen M, Hiesmayr J.M, Horbach T, Kuse E.R, Vestweber K.H. DGEM-Leitlinie Enterale Ernährung: Chirurgie und Transplantation. Aktuel Ernaehr Med 2003; 28:51-60
8. Zhong Z, Wheeler MD, Froh M, Schemmer P, Yin M, Bunzendahl H, Bradford BU, Lemasters JJ. L-Glycine: a novel anti-inflammatory, immunomodulatory, and cytoprotective agent. Curr opin Clin Nutr Metab Care 2003; 6:229-40
9. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-40
10. Berger D, Schmidt UM, Otto S, Seidelmann M, Martin R, Beger HG. Incidence of pathophysiological relevance of postoperative endotoxemia. FEMS Immunolog Med Microbiol 1995; 11:285-90
11. Roumen RM, Frieling JT, van Tits HW, et al. Endotoxemia after major vascular operations. J Vasc Surg 1993; 18:853-7
12. Soong CV, Blair PH, Halliday MI, et al. Endotoxemia, the generation of cytokines and their relationship in intramucosal acidosis of the sigmoid colon in elective abdominal aneurysm repair. Eur J Vasc Surg 1993; 14:534-9
13. Buttenschoen K, Buttenschoen DC, Berger D, et al. Endotoxemia and acute- phase proteins in major abdominal surgery. Am J Surg 2001; 181:36-43
14. Berger D, Bölke E, Huegel H, Deidelmann M, Hannekum A, Beger HG. New aspects concerning the regulation of the post-operative acute phase reaction during cardiac surgery. Clin Chim Acta 1995; 239:121-30
15. Berger D, Otto S, Schmidt UM, Bölke E, Seidelmann M, Beger HG. Determination of endotoxin-neutralizing capacity of plasma in post-surgical patients. Eur Surg Res 1996; 28:130-9
16. Hiki N, Berger D, Buttenschoen K, Boelke E, Seidelmann M, Strecker W, Kinzl L, Beger HG. Endotoxemia and specific antibody behaviour against different endotoxins following multiple injuries. J Trauma 1995; 38:794-801
17. Bennet-Guerrero E, Panah MH, Barclay GB, Bodian CA, Winfree WJ, Andres LA, Reich DL, Mythen MG. Decreased endotoxin immunity is associated with greater mortality and/or prologed hospitalization after surgery. Anesthesiology 2001; 94:992-8
18. Snyderman CH, Kachman K, Molseed L, Wagner R, D'Amico F, Bumpous J, Rueger R. Reduced postoperative infections with an immune-enhancing nutritional supplement. Laryngoscope 1999; 109:915-21
19. Braga M, Gianotti L, Vignali A, Carlo VD. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic response and outcome after colorectal resection for cancer. Surgery 2002; 132:805-14
20. Braga M, Gianotti L, Nespoli L, Radealli G, Di Carlo V. Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg 2002; 137:174-80
21. Zulfikaroglu B, Zulfikaroglu E, Ozmen MM, Ozalp N, Berkem R, Erdogan S, Besler HT, Koc M, Korkmaz A. The effect of immunonutrition on bacterial translocation, and intestinal villus atrophy in experimental obstructive jaundice. Clin Nutr 2003; 22:277-81
22. Tracey KJ, Vlassara H, Cerami A. Cachetin/tumour necrosis factor. Lancet 1989; 8527:1122-6
23. Hesse DG, Tracey KJ, Fong Y, Manogue KR, Palladino MA Jr, Cerami A, Shires GT, Lowry SF. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 1988; 166:147-153
24. Fong Y, Moldawar LL, Marano M. Cachetin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Am J Physiol 1989; 256:659-65
25. Dinarello CA, Cannon JG, Wolff SM. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1. J Exp Med 1986; 163:1433-50
26. Calandra T, Baumgartner JD, Grau GE. Prognostic value of tumor necrosis factor-cachectin, interleukin-1, interferon-alpha and interferon-gamma in the serum of patients with septic shock. J Infect Dis 1990; 161:982-7
27. Waage A, Halstensen A, Spevik T. Association between tumor necrosis factor in serum and total outcome in patients with meningococcal disease. Lancet 1987; 8527:355-7
28. Senkal M, Kemen M, Homann HH, Eickhoff U, Baier J, Zumtobel V. Modulation of postoperative immune response by enteral nutrition with a diet enriched with arginine, RNA, and omega-3 fatty acids in patients with upper gastrointestinal cancer. Eur J Surg 1995; 161:115-22
29. Gianotti L, Braga M, Fortis C, Soldini L, Vignali A, Colombo S, Radealli G, Di Carlo V. A prospective, randomized clinical trial on perioperative feeding with an arginine-, omega-3 fatty acid-, and RNA-enriched enteral diet: effect on host response and nutritional status. JPEN 1999; 6:314-20
30. 2 interferon by human fibroblasts. J Exp Med 1987; 166:1300-9
31. Delogu G, Casula MA, Mancini P, Tellan G, Signore L. Serum neopterin and soluble interleukin-2 receptor for prediction of a shock state in gram-negative sepsis. J Crit Care 1995: 10:64-71
32. Strohmaier W, Redl H, Schlag G, Inthorn D. D-erythro-neopterin plasma levels in intensive care patients with and without septic complications. Crit Care Med 1987; 15:757-60